Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin

Ruecker, Frank G.; Bullinger, Lars; Cocciardi, Sibylle; Skambraks, Sabrina; Luck, Tamara J.; Weber, Daniela; Krzykalla, Julia; Pozek, Ema; Schneider, Isabelle; Corbacioglu, Andrea; Gaidzik, Verena I.; Meid, Annika; Aicher, Sophia; Stegelmann, Frank; Schrade, Anika; Theis, Frauke; Fiedler, Walter; Salih, Helmut R.; Wulf, Gerald; Salwender, Hans; Schroeder, Thomas; Goetze, Katharina S.; Kuehn, Michael W. M.; Luebbert, Michael; Schlenk, Richard F.; Benner, Axel; Thol, Felicitas; Heuser, Michael; Ganser, Arnold; Doehner, Hartmut; Doehner, Konstanze

Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin

Autor(en):

Ruecker, Frank G.; Bullinger, Lars; Cocciardi, Sibylle; Skambraks, Sabrina; Luck, Tamara J.; Weber, Daniela; Krzykalla, Julia; Pozek, Ema; Schneider, Isabelle; Corbacioglu, Andrea; Gaidzik, Verena I.; Meid, Annika; Aicher, Sophia; Stegelmann, Frank; Schrade, Anika; Theis, Frauke; Fiedler, Walter; Salih, Helmut R.; Wulf, Gerald; Salwender, Hans; Schroeder, Thomas; Goetze, Katharina S.; Kuehn, Michael W. M.; Luebbert, Michael; Schlenk, Richard F.; Benner, Axel; Thol, Felicitas; Heuser, Michael; Ganser, Arnold; Doehner, Hartmut; Doehner, Konstanze

Tübinger Autor(en):

Salih, Helmut R.

Erschienen in:

Blood Advances (2024), Bd. 8, H. 23, S. 6067-6080

Verlagsangabe:

Amsterdam : Elsevier

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1182/bloodadvances.2024013758

ISSN:

2473-9529